Anthony Hunt, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 33,258 shares at $201.75 ($6.6M) on 2024-03-08, disclosed to the SEC on 2024-03-11.
Scheduled sale ($6.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $195.49 | 3,377 | $660K | 10.1% |
| 2 | $195.49 | 3,377 | $660K | 10.1% |
| 3 | $196.32 | 6,228 | $1.2M | 18.6% |
| 4 | $196.32 | 6,228 | $1.2M | 18.6% |
| 5 | $197.39 | 1,666 | $329K | 5.0% |
| 6 | $197.39 | 1,666 |
| $329K |
| 5.0% |
| 7 | $198.55 | 1,347 | $267K | 4.1% |
| 8 | $198.55 | 1,347 | $267K | 4.1% |
| 9 | $199.53 | 1,822 | $364K | 5.5% |
| 10 | $199.53 | 1,822 | $364K | 5.5% |
| 11 | $200.56 | 1,305 | $262K | 4.0% |
| 12 | $200.56 | 1,305 | $262K | 4.0% |
| 13 | $201.75 | 806 | $163K | 2.5% |
| 14 | $201.75 | 806 | $163K | 2.5% |
| 15 | $202.55 | 156 | $32K | 0.5% |
| Total | $197.42 avg | 33,258 | $6.6M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |